ADVFN - Advanced Financial Network.
HOME» NYSE » F » FRX Stock Price » FRX Stock News

Forest Labs Share News

 Forest Laboratories, Inc. Stock Price
FRX Stock Price
 Forest Laboratories, Inc. Stock Chart
FRX Stock Chart
 Forest Laboratories, Inc. Stock News
FRX Stock News
 Forest Laboratories, Inc. Company Information
FRX Company Information
 Forest Laboratories, Inc. Stock Trades
FRX Stock Trades

Forest Laboratories 2Q Profit Doubles On Fewer Charges, Costs

DOW JONES NEWSWIRES Forest Laboratories Inc.'s (FRX) second-quarter earnings more than doubled on fewer charges and lower expenses. Like many drug makers, Forest Labs has sought to partner with drug developers to bolster its pipeline. Patent protection for its main money maker, the depression treatment Lexapro, expires in March 2012. The company acquired Clinical Data Inc. in April for $1.2 billion in a bet that the antidepressant Viibryd can help offset the looming loss of patent protection for Lexapro and its No. 2 drug, Namenda, which treats Alzheimer's and dementia. Sales of Lexapro have slowed in the past year amid competition but rose 3.6% in the quarter to $585.7 million while Namenda sales increased 3.9% to $319.9 million. Forest Labs reported a profit of $258.1 million, or 90 cents a share, up from $117.5 million, or 39 cents a share, a year earlier. Excluding items, earnings rose to $1.04 from 95 cents. The most-recent quarter included a 14-cent charge on a licensing payment to Blue Ash for azimilide, while the year-earlier quarter included charges related to Department of Justice investigations and a licensing payment to TransTech for glucose-lowering agents. Revenue jumped 8% to $1.15 billion. Analysts polled by Thomson Reuters had most recently forecast earnings of 97 cents on revenue of $1.13 billion. The company's costs and expenses fell 10% to $806.3 million Shares closed Monday at $37.95 and were inactive premarket. The stock has risen 34% over the past year. -By Melodie Warner, Dow Jones Newswires; 212-416-2283;

Stock News for Forest Labs (FRX)
06/24/201418:58:22Affiliated Managers Group to Join S&P 500
06/24/201409:51:44U.S. Hot Stocks: Hot Stocks to Watch
06/23/201418:21:28Forest Labs Posts Positive Results for Anxiety Disorder Drug
05/15/201418:00:08Third Point Adds New Stakes in American Airlines, Anheuser-Busch
05/14/201409:40:15Forest Labs' Saunders to Head Actavis After Deal
04/28/201417:23:16MARKET SNAPSHOT: U.S. Stocks End Choppy Trade Higher
04/28/201417:00:57MARKET SNAPSHOT: U.S. Stock Gains Fizzle As Internet Leaders...
04/28/201416:50:40MARKET SNAPSHOT: U.S. Stocks Rise Sharply On Deal News; Charter...
04/28/201416:49:07MARKET SNAPSHOT: U.S. Stocks Rise; Charter Rallies On Deal News
02/25/201407:20:12TPG 'Contemplating' Going Public
02/24/201417:01:35MARKET SNAPSHOT: Stocks Rally; S&P 500 Ends Right Below Record
02/24/201413:53:12MARKET SNAPSHOT: U.S. Stocks Rally As S&P 500 Hits Intraday Record
02/24/201405:47:09MARKET SNAPSHOT: U.S. Stock Market Is Starting To Ride A Tech...
02/18/201416:54:11MARKET SNAPSHOT: U.S. Stocks Edge Up; Nasdaq Gains For 8th Day...
02/18/201415:35:34MARKET SNAPSHOT: U.S. Stocks Churn; Coke Weighs On Dow, Nasdaq...
02/18/201411:32:36MARKET SNAPSHOT: U.S. Stock Gains Muted By Data; Coke Weighs...
02/18/201411:04:34MARKET SNAPSHOT: U.S. Stocks Edge Lower After Weak Data
02/18/201410:16:54MARKET SNAPSHOT: U.S. Stocks Edge Higher; Manufacturing Data...
01/21/201417:07:35MARKET SNAPSHOT: U.S. Stocks Close Higher; Earnings Misses Drag...
01/21/201412:37:10MARKET SNAPSHOT: U.S. Stocks Rise On China; J&J Drags On Dow

Forest Labs and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations